Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can ...
Cross Country Healthcare has seen a material decline in their share price, down 60% from the high in November 2022 following the travel nurse industry declines. There's likely still more softness ...
Fintel on MSN
Benchmark upgrades Cross Country Healthcare (CCRN)
Fintel reports that on March 5, 2026, Benchmark upgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Hold to Buy. Analyst Price Forecast Suggests 27.10% Upside As of February 25, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results